Title : Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial.

Pub. Date : 2011 Aug 15

PMID : 21792049






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial. Sirolimus calcineurin binding protein 1 Homo sapiens